nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—HTR2A—conduct disorder	0.882	1	CbGaD
Mesoridazine—DRD3—Dopamine receptors—DRD4—conduct disorder	0.00834	0.0757	CbGpPWpGaD
Mesoridazine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00638	0.0579	CbGpPWpGaD
Mesoridazine—HTR6—Serotonin receptors—HTR2A—conduct disorder	0.00318	0.0289	CbGpPWpGaD
Mesoridazine—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00264	0.024	CbGpPWpGaD
Mesoridazine—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.00235	0.0214	CbGpPWpGaD
Mesoridazine—HTR2C—Serotonin receptors—HTR2A—conduct disorder	0.00234	0.0213	CbGpPWpGaD
Mesoridazine—HTR6—Monoamine GPCRs—DRD4—conduct disorder	0.00217	0.0197	CbGpPWpGaD
Mesoridazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00202	0.0184	CbGpPWpGaD
Mesoridazine—DRD3—Monoamine GPCRs—DRD4—conduct disorder	0.00184	0.0167	CbGpPWpGaD
Mesoridazine—HTR6—Amine ligand-binding receptors—DRD4—conduct disorder	0.00182	0.0166	CbGpPWpGaD
Mesoridazine—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.00161	0.0146	CbGpPWpGaD
Mesoridazine—HTR2C—Monoamine GPCRs—DRD4—conduct disorder	0.0016	0.0145	CbGpPWpGaD
Mesoridazine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.00156	0.0141	CbGpPWpGaD
Mesoridazine—DRD3—Amine ligand-binding receptors—DRD4—conduct disorder	0.00155	0.0141	CbGpPWpGaD
Mesoridazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00144	0.0131	CbGpPWpGaD
Mesoridazine—HTR6—Monoamine GPCRs—HTR2A—conduct disorder	0.00142	0.0129	CbGpPWpGaD
Mesoridazine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00141	0.0128	CbGpPWpGaD
Mesoridazine—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.00139	0.0126	CbGpPWpGaD
Mesoridazine—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.00138	0.0126	CbGpPWpGaD
Mesoridazine—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.00136	0.0124	CbGpPWpGaD
Mesoridazine—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00135	0.0123	CbGpPWpGaD
Mesoridazine—HTR6—G alpha (s) signalling events—CGA—conduct disorder	0.00134	0.0122	CbGpPWpGaD
Mesoridazine—HTR2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.00134	0.0122	CbGpPWpGaD
Mesoridazine—DRD3—Monoamine GPCRs—HTR2A—conduct disorder	0.0012	0.0109	CbGpPWpGaD
Mesoridazine—HTR6—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00119	0.0108	CbGpPWpGaD
Mesoridazine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00118	0.0108	CbGpPWpGaD
Mesoridazine—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00117	0.0106	CbGpPWpGaD
Mesoridazine—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00116	0.0106	CbGpPWpGaD
Mesoridazine—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00114	0.0104	CbGpPWpGaD
Mesoridazine—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.00105	0.00951	CbGpPWpGaD
Mesoridazine—HTR2C—Monoamine GPCRs—HTR2A—conduct disorder	0.00104	0.00947	CbGpPWpGaD
Mesoridazine—DRD3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00101	0.00918	CbGpPWpGaD
Mesoridazine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.00092	0.00835	CbGpPWpGaD
Mesoridazine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.000903	0.0082	CbGpPWpGaD
Mesoridazine—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.000889	0.00807	CbGpPWpGaD
Mesoridazine—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000881	0.008	CbGpPWpGaD
Mesoridazine—HTR2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000876	0.00796	CbGpPWpGaD
Mesoridazine—Propiomazine—DRD4—conduct disorder	0.000846	0.101	CrCbGaD
Mesoridazine—DRD3—GPCRs, Other—DRD4—conduct disorder	0.000818	0.00743	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000786	0.00714	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—GABRA2—conduct disorder	0.000777	0.00706	CbGpPWpGaD
Mesoridazine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000773	0.00702	CbGpPWpGaD
Mesoridazine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000759	0.00689	CbGpPWpGaD
Mesoridazine—Cyamemazine—HTR2A—conduct disorder	0.000759	0.0903	CrCbGaD
Mesoridazine—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000747	0.00678	CbGpPWpGaD
Mesoridazine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00073	0.00663	CbGpPWpGaD
Mesoridazine—Methotrimeprazine—DRD4—conduct disorder	0.000723	0.0861	CrCbGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00064	0.00582	CbGpPWpGaD
Mesoridazine—Promazine—DRD4—conduct disorder	0.000627	0.0746	CrCbGaD
Mesoridazine—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000616	0.0056	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.000605	0.00549	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000591	0.00537	CbGpPWpGaD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000584	0.0053	CbGpPWpGaD
Mesoridazine—Chlorpromazine—DRD4—conduct disorder	0.000551	0.0656	CrCbGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000544	0.00494	CbGpPWpGaD
Mesoridazine—DRD3—GPCRs, Other—HTR2A—conduct disorder	0.000534	0.00485	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000493	0.00448	CbGpPWpGaD
Mesoridazine—Acepromazine—HTR2A—conduct disorder	0.000488	0.058	CrCbGaD
Mesoridazine—HTR6—GPCR ligand binding—CGA—conduct disorder	0.000488	0.00443	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000482	0.00438	CbGpPWpGaD
Mesoridazine—Thioproperazine—HTR2A—conduct disorder	0.000477	0.0567	CrCbGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000474	0.00431	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000472	0.00428	CbGpPWpGaD
Mesoridazine—Thiothixene—HTR2A—conduct disorder	0.000469	0.0558	CrCbGaD
Mesoridazine—Pipotiazine—HTR2A—conduct disorder	0.000469	0.0558	CrCbGaD
Mesoridazine—DRD3—Circadian rythm related genes—SLC6A4—conduct disorder	0.000462	0.00419	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—DRD4—conduct disorder	0.000434	0.00394	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000426	0.00387	CbGpPWpGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000419	0.0038	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000418	0.0038	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000416	0.00378	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—CGA—conduct disorder	0.000414	0.00376	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00041	0.00372	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000409	0.00371	CbGpPWpGaD
Mesoridazine—Fluphenazine—HTR2A—conduct disorder	0.000405	0.0482	CrCbGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000402	0.00365	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.000395	0.00358	CbGpPWpGaD
Mesoridazine—Propiomazine—HTR2A—conduct disorder	0.00039	0.0464	CrCbGaD
Mesoridazine—DRD3—G alpha (i) signalling events—DRD4—conduct disorder	0.000383	0.00348	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—COMT—conduct disorder	0.000374	0.0034	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—MAOA—conduct disorder	0.000371	0.00337	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000371	0.00337	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000361	0.00328	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.000359	0.00326	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000359	0.00326	CbGpPWpGaD
Mesoridazine—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000356	0.00323	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000353	0.00321	CbGpPWpGaD
Mesoridazine—Thioridazine—HTR2A—conduct disorder	0.000349	0.0416	CrCbGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000334	0.00303	CbGpPWpGaD
Mesoridazine—Methotrimeprazine—HTR2A—conduct disorder	0.000333	0.0397	CrCbGaD
Mesoridazine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000332	0.00302	CbGpPWpGaD
Mesoridazine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000331	0.003	CbGpPWpGaD
Mesoridazine—Promethazine—HTR2A—conduct disorder	0.000328	0.0391	CrCbGaD
Mesoridazine—Trifluoperazine—HTR2A—conduct disorder	0.000324	0.0386	CrCbGaD
Mesoridazine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000323	0.00293	CbGpPWpGaD
Mesoridazine—Perphenazine—HTR2A—conduct disorder	0.00032	0.0381	CrCbGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00032	0.00291	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000317	0.00288	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000315	0.00286	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000312	0.00283	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.000311	0.00283	CbGpPWpGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00031	0.00281	CbGpPWpGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000308	0.0028	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.000306	0.00278	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000305	0.00277	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000302	0.00275	CbGpPWpGaD
Mesoridazine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000293	0.00266	CbGpPWpGaD
Mesoridazine—Promazine—HTR2A—conduct disorder	0.000289	0.0344	CrCbGaD
Mesoridazine—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.000283	0.00257	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—CGA—conduct disorder	0.000276	0.0025	CbGpPWpGaD
Mesoridazine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000273	0.00248	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—DRD4—conduct disorder	0.000273	0.00248	CbGpPWpGaD
Mesoridazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000272	0.00247	CbGpPWpGaD
Mesoridazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000268	0.00243	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000267	0.00243	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000265	0.00241	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000264	0.0024	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000263	0.00239	CbGpPWpGaD
Mesoridazine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.00026	0.00236	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000256	0.00233	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000255	0.00232	CbGpPWpGaD
Mesoridazine—Chlorpromazine—HTR2A—conduct disorder	0.000254	0.0303	CrCbGaD
Mesoridazine—HTR6—Signaling by GPCR—CGA—conduct disorder	0.00025	0.00227	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000234	0.00213	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000234	0.00213	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000233	0.00212	CbGpPWpGaD
Mesoridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000233	0.00211	CbGpPWpGaD
Mesoridazine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000232	0.00211	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000232	0.00211	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000229	0.00208	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000229	0.00208	CbGpPWpGaD
Mesoridazine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000225	0.00205	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000225	0.00205	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000213	0.00193	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000204	0.00185	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000203	0.00184	CbGpPWpGaD
Mesoridazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000202	0.00184	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000202	0.00184	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000202	0.00183	CbGpPWpGaD
Mesoridazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000201	0.00183	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000201	0.00183	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000199	0.00181	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000185	0.00168	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000184	0.00167	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000179	0.00163	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—HTR2A—conduct disorder	0.000178	0.00162	CbGpPWpGaD
Mesoridazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000177	0.00161	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000177	0.00161	CbGpPWpGaD
Mesoridazine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000177	0.00161	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000176	0.0016	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000176	0.0016	CbGpPWpGaD
Mesoridazine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000176	0.0016	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000175	0.00159	CbGpPWpGaD
Mesoridazine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000174	0.00158	CbGpPWpGaD
Mesoridazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000174	0.00158	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000174	0.00158	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000173	0.00157	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000173	0.00157	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000172	0.00157	CbGpPWpGaD
Mesoridazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000171	0.00156	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.000171	0.00156	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000163	0.00148	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00016	0.00145	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.00016	0.00145	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00016	0.00145	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.000157	0.00143	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	0.000154	0.0014	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000152	0.00138	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	0.000151	0.00137	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—EP300—conduct disorder	0.00015	0.00136	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000149	0.00136	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CGA—conduct disorder	0.000148	0.00134	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000147	0.00133	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—DRD4—conduct disorder	0.00014	0.00127	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000138	0.00126	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000136	0.00123	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000132	0.0012	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.000131	0.00119	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	0.000131	0.00119	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CGA—conduct disorder	0.000126	0.00114	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—DRD4—conduct disorder	0.000119	0.00108	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—WASF1—conduct disorder	0.000118	0.00108	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000116	0.00105	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000115	0.00104	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.000114	0.00104	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	0.000114	0.00103	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	0.000114	0.00103	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.000112	0.00102	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CGA—conduct disorder	0.000109	0.000994	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CGA—conduct disorder	0.000109	0.000989	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	0.000104	0.000942	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	0.000103	0.000937	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	0.000101	0.000915	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—WASF1—conduct disorder	0.000101	0.000914	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.0001	0.000911	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	9.87e-05	0.000896	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	9.85e-05	0.000894	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	9.69e-05	0.00088	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CGA—conduct disorder	9.61e-05	0.000873	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CGA—conduct disorder	9.45e-05	0.000859	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CGA—conduct disorder	9.43e-05	0.000857	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CGA—conduct disorder	9.28e-05	0.000843	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	9.14e-05	0.000831	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	9.11e-05	0.000827	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	8.96e-05	0.000814	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—DRD4—conduct disorder	8.94e-05	0.000812	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	8.8e-05	0.000799	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—WASF1—conduct disorder	8.77e-05	0.000797	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—WASF1—conduct disorder	8.73e-05	0.000792	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	8.55e-05	0.000777	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—DRD4—conduct disorder	8.28e-05	0.000752	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	7.77e-05	0.000705	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—WASF1—conduct disorder	7.7e-05	0.000699	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	7.58e-05	0.000688	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—WASF1—conduct disorder	7.56e-05	0.000687	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	7.45e-05	0.000677	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	7.44e-05	0.000676	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	7.42e-05	0.000673	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—DRD4—conduct disorder	7.03e-05	0.000639	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	6.77e-05	0.000615	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	6.73e-05	0.000612	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CGA—conduct disorder	6.7e-05	0.000609	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	6.54e-05	0.000594	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	6.43e-05	0.000584	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	6.32e-05	0.000574	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DRD4—conduct disorder	6.13e-05	0.000557	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DRD4—conduct disorder	6.1e-05	0.000554	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	5.94e-05	0.00054	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	5.83e-05	0.00053	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	5.74e-05	0.000521	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HTR2A—conduct disorder	5.4e-05	0.000491	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—DRD4—conduct disorder	5.38e-05	0.000489	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	5.29e-05	0.000481	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DRD4—conduct disorder	5.28e-05	0.00048	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	5.2e-05	0.000472	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HTR2A—conduct disorder	4.59e-05	0.000417	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	4e-05	0.000363	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	3.98e-05	0.000361	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.51e-05	0.000319	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HTR2A—conduct disorder	3.45e-05	0.000313	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	3.39e-05	0.000308	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—COMT—conduct disorder	3.03e-05	0.000275	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MAOA—conduct disorder	3e-05	0.000273	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EP300—conduct disorder	2.86e-05	0.00026	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EP300—conduct disorder	2.43e-05	0.000221	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EP300—conduct disorder	2.12e-05	0.000192	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EP300—conduct disorder	2.11e-05	0.000191	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.86e-05	0.000169	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.83e-05	0.000166	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EP300—conduct disorder	1.83e-05	0.000166	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EP300—conduct disorder	1.8e-05	0.000163	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—EP300—conduct disorder	1.3e-05	0.000118	CbGpPWpGaD
